Investors

Stock price graph
     

BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders.

View all »   RSSRecent Releases

Aug 14, 2014
BG Medicine Reports Second Quarter 2014 Financial Results

Aug 7, 2014
BG Medicine Announces Q2 2014 Financial Results Release Date and Conference Call Information